Investing responsibly - Celebrating 20 years of investor engagement

However, the decade ahead is critical for securing a sustainable future for us all

JOIN US ON THE JOURNEY

Committed to our clients

We want to keep you updated about what we are doing to address COVID-19.

FIND OUT MORE

Multi-Asset investing for sustainable returns

BMO Sustainable Multi-Asset Income Fund

FIND OUT MORE

The value of investments and any income derived from them can go down as well as up as a result of market or currency movements and investors may not get back the original amount invested.

Our Capabilities

Responsible Investment

Responsible solutions from a pioneer in ESG investing.

Fixed income

A range of solutions built from wide ranging capabilities in bond investing.

Multi-asset

Outcome orientated active investing across asset classes.

Real Estate

Real assets with real potential – investing directly and indirectly in property.

Emerging markets

Actively targeting growth potential at its most potent.

 

Style investing

Systematically targeting the performance potential of style investing.

News & Insights

A wide range of news and views articles from our fund managers, economists and industry experts

No posts matching your criteria
3 min read

Where will the Vaccine take us?

Steven Bell looks at what the introduction of the new vaccine could mean for the economy.

3 min read

How can investors unlock sustainable opportunities?

How to embrace the opportunities that change creates

20 min listen

Achieving sustainability in the food production system

David Sneyd is joined by Jo Raven from the FAIRR Initiative to discuss the progress that is already underway to create a more sustainable food production system, including the rise of alternative, plant-based proteins in the food supply chain.

10 min read

Responsible Global Emerging Markets Strategy - Q3 2020

The team at LGM provide their regular update on responsible investing in emerging markets.

2 min read

Why does antimicrobial resistance matter to food companies?

Antimicrobial resistance is accelerating at a rate that could threaten modern medicine. Why is it a material issue for food companies?

2 min read

Why does antimicrobial resistance matter to pharmaceutical companies?

Antimicrobial resistance threatens our entire healthcare ecosystem. Why is it a particularly pressing issue for pharmaceutical companies?

5 min watch

Investors look set to put cash to work

Macro Update 16 November 2020

6 min watch

Vaccine comes to the rescue

Macro Update 09 November 2020

4 min read

The COVID-19 effect: Cybersecurity and data privacy

Discover how COVID-19 is impacting cybersecurity and data privacy

6 min watch

Vaccines + elections = great uncertainty

Macro Update 26 October 2020